EUVIMEDEUVIMED entdecken
Open Access

Preclinical Evaluation of 177 Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy

Caroline Foxton, Bradley Waldron, Rikke Veggerby Grønlund, Jaime Jim Simón, Bart Cornelissen, Edward O'Neill, Daniel Stevens

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.268508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Caroline Foxton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Blue Earth Diagnostics Ltd., Oxford, United Kingdom; caroline.foxton@blueearthdx.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiopharmaceuticals, Lutetium, Radioisotopes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiopharmaceuticalsLutetiumRadioisotopesAnimalsMaleMiceHumansTissue DistributionCell Line, TumorMice, Inbred BALB CTreatment OutcomeXenograft Model Antitumor AssaysGlutamate Carboxypeptidase IIProstate-Specific Antigen

Stichwörter der Autor:innen

PSMAbiodistributionpreclinicalprostate cancerradiopharmaceutical

Substanzen

RadiopharmaceuticalsLutetiumRadioisotopesLutetium-177Glutamate Carboxypeptidase IIProstate-Specific Antigen

Autor:innen und Institutionen

  • Blue Earth Diagnostics Ltd., Oxford, United Kingdom; caroline.foxton@blueearthdx.com.
  • Blue Earth Therapeutics Ltd., Oxford, United Kingdom.
  • Minerva Imaging, Ølstykke, Denmark.
  • IsoTherapeutics Group LLC, Angleton, Texas; and.
  • Department of Oncology, University of Oxford, Oxford, United Kingdom.

Zitieren

APA

Foxton, C., Waldron, B., Veggerby Grønlund, R., Simón, J. J., Cornelissen, B., O'Neill, E., & Stevens, D. (2025). Preclinical Evaluation of 177 Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268508

Vancouver

Foxton C, Waldron B, Veggerby Grønlund R, Simón JJ, Cornelissen B, O'Neill E, et al. Preclinical Evaluation of 177 Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268508

BibTeX
@article{Foxton2025,
  author = {Foxton, Caroline and Waldron, Bradley and Veggerby Grønlund, Rikke and Simón, Jaime Jim and Cornelissen, Bart and O'Neill, Edward and Stevens, Daniel},
  title = {Preclinical Evaluation of 177 Lu-rhPSMA-10.1, a Radiopharmaceutical for Prostate Cancer: Biodistribution and Therapeutic Efficacy},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.268508}
}
Kostenlos starten →